Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression

Free Radical Research

Volumn 48, Issue 5, 2014, Pages 526-533

  Cannizzo, B ^a   Quesada, I ^a   Militello, R ^a   Amaya, C ^a   Miatello, R ^a   Cruzado, M ^a   Castro, C ^a  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

Author keywords

Atherosclerosis; NADPH oxidase; Oxidative stress; Tempol

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; FRUCTOSE; GLUCOSE; INSULIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TEMPOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; AMINE OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPIN LABELING;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTA WALL; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SUGAR INTAKE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; VASCULITIS; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; COMPLICATION; INFLAMMATION; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SPIN LABELING;

ANIMALS; ATHEROSCLEROSIS; CYCLIC N-OXIDES; INFLAMMATION; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SPIN LABELS;

EID: 84897532709     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.889295     Document Type: Article

References (36)

1. Fearon IM , Faux SP . Oxidative stress and cardiovascular disease: novel tools give (free) radical insight . J Mol Cell Cardiol 2009; 47: 372- 381.
2. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H . Role of oxidative stress in atherosclerosis . Am J Cardiol 2003; 91: 7A-11A.
3. Sorescu D, Szocs K, Griendling KK . NAD(P)H oxidases and their relevance to atherosclerosis . Trends Cardiovasc Med 2001 ; 11: 124-131 .
4. Muller G, Morawietz H . Nitric oxide, NAD(P)H oxidase and atherosclerosis . Antioxid Redox Signal 2009 ; 11: 1711-1731 .
5. Collin B, Busseuil D, Zeller M, Perrin C, Barthez O, Duvillard L, et al . Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model . Mol Cell Biochem 2007 ; 294: 225-235 .
6. Vendrov AE, Hakim ZS, Madamanchi NR, Rojas M, Madamanchi C, Runge MS . Atherosclerosis is attenuated by limiting oxidant generation in both macrophages and vessel wall cells . Arterioscler Thromb Vasc Biol 2007 ; 27: 2714-2721 .
7. Cruzado MC, Risler NR, Miatello RM, Yao G, Schiff rin EL, Touyz RM . Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation . Am J Hypertens 2005 ; 18: 81-87
8. Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y . High fructose feeding of magnesium defi cient rats is associated with increased plasma triglyceride concentration and increased oxidative stress. Magnes Res 2003; 16: 7-12.
9. Cannizzo B, Lujan A, Estrella N, Lembo C, Cruzado M, Castro C . Insulin resistance promotes early atherosclerosis via increased proinfl ammatory proteins and oxidative stress in fructose-fed ApoE-KO mice . Exp Diabetes Res 2012 ; 2012: 941304 .
10. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, et al . Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II . Circ Res 2002; 90: 1205-1213.
11. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M . Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology . Arterioscler Thromb Vasc Biol 2000 ; 20: 2175-2183 .
12. Drummond GR, Selemidis S, Griendling KK, Sobey CG . Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets . Nat Rev Drug Discov 2011 ;10: 453-471 .
13. Shin MH, Moon YJ, Seo JE, Lee Y, Kim KH, Chung JH . Reactive oxygen species produced by NADPH oxidase, xanthine oxidase, and mitochondrial electron transport system mediate heat shock-induced MMP-1 and MMP-9 expression . Free Radic Biol Med 2008; 44: 635-645.
14. Poitevin S, Garnotel R, Antonicelli F, Gillery P, Nguyen P . Type I collagen induces tissue factor expression and matrix metalloproteinase 9 production in human primary monocytes through a redox-sensitive pathway . J Thromb Haemost 2008 ; 6: 1586-1594 .
15. Rizvi AA . Cytokine biomarkers, endothelial infl ammation, and atherosclerosis in the metabolic syndrome: emerging concepts . Am J Med Sci 2009 ; 338: 310-318 .
16. Gimbrone MA Jr, Bevilacqua MP, Cybulsky MI . Endothelialdependent mechanisms of leukocyte adhesion in infl ammation and atherosclerosis . Ann N Y Acad Sci 1990 ; 598: 77-85 .
17. Guardamagna O, Abello F, Saracco P, Baracco V, Rolfo E, Pirro M . Endothelial activation, infl ammation and premature atherosclerosis in children with familial dyslipidemia . Atherosclerosis 2009 ; 207: 471-475 .
18. Peter K, Weirich U, Nordt TK, Ruef J, Bode C . Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis . Thromb Haemost 1999 ; 82: 38-43 .
19. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R . Upregulation of VCAM-1 and ICAM-1 at atherosclerosisprone sites on the endothelium in the ApoE-defi cient mouse . Arterioscler Thromb Vasc Biol 1998 ; 18: 842-851 .
20. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E . Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study . Circulation1997 ; 96: 4219-4225 .
21. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A . The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis . J Pathol 1993 ; 171: 223-229 .
22. Deem TL, Cook-Mills JM . Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species . Blood 2004 ; 104: 2385-2393 .
23. Park JG, Ryu SY, Jung IH, Lee YH, Kang KJ, Lee MR, et al . Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-defi cient mice . Atherosclerosis 2013 ; 2226: 3356-3363 .
24. Gamkrelidze M, Mamamtavrishvili N, Bejitashvili N, Sanikidze T, Ratiani L . Role of oxidative stress in pathogenesis of atherosclerosis . Georgian Med News 2008 ;( 163): 54-57 .
25. Koh KK, Oh PC, Quon MJ . Does reversal of oxidative stress and infl ammation provide vascular protection? Cardiovasc Res 2009 ; 81: 649-659 .
26. Nauseef WM . Biological roles for the NOX family NADPH oxidases . J Biol Chem 2008 ; 283: 16961-16965 .
27. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, et al . Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat . Atherosclerosis 2005 ; 179: 43-49 .
28. Wilcox CS . Effects of tempol and redox-cycling nitroxides in models of oxidative stress . Pharmacol Ther 2010 ; 126: 119-145 .
29. Giera M, Lingeman H, Niessen WM . Recent advancements in the LC-and GC-based analysis of Malondialdehyde (MDA): a brief overview . Chromatographia 2012; 75: 433-440.
30. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM . Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000; 86: E85-90.
31. Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR . NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition . Pharmacol Ther 2008 ; 120: 254-291 .
32. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS . p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice . J Clin Invest 2001 ; 108: 1513-1522 .
33. Ortiz MC, Manriquez M, Romero J, Juncos L . Antioxidants block angiotensin II-induced increases in blood pressure and endothelin . Hypertension 2001 ; 38: 655-659 .
34. Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, et al . Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats . Nephrol Dial Transplant 2010 ; 25: 389-399 .
35. Park JB, Touyz RM, Chen X, Schiff rin EL . Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats . Am J Hypertens 2002 ; 15: 78-84 .
36. Jagadeesha DK, Lindley TE, Deleon J, Sharma RV, Miller F, Bhalla RC . Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats . Am J Physiol Heart Circ Physiol 2005; 289: H1047-1053.